Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 4
2014 4
2015 4
2016 1
2017 2
2019 1
2020 4
2021 5
2022 4
2023 8
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Probiotics in Functional Dyspepsia.
Tziatzios G, Gkolfakis P, Leite G, Mathur R, Damoraki G, Giamarellos-Bourboulis EJ, Triantafyllou K. Tziatzios G, et al. Among authors: damoraki g. Microorganisms. 2023 Jan 31;11(2):351. doi: 10.3390/microorganisms11020351. Microorganisms. 2023. PMID: 36838317 Free PMC article. Review.
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly.
Giamarellos-Bourboulis EJ, Tsilika M, Moorlag S, Antonakos N, Kotsaki A, Domínguez-Andrés J, Kyriazopoulou E, Gkavogianni T, Adami ME, Damoraki G, Koufargyris P, Karageorgos A, Bolanou A, Koenen H, van Crevel R, Droggiti DI, Renieris G, Papadopoulos A, Netea MG. Giamarellos-Bourboulis EJ, et al. Among authors: damoraki g. Cell. 2020 Oct 15;183(2):315-323.e9. doi: 10.1016/j.cell.2020.08.051. Epub 2020 Sep 1. Cell. 2020. PMID: 32941801 Free PMC article. Clinical Trial.
Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality.
Giamarellos-Bourboulis EJ, Antonelli M, Bloos F, Kotsamidi I, Psarrakis C, Dakou K, Thomas-Rüddel D, Montini L, Briegel J, Damoraki G, Koufargyris P, Anisoglou S, Antoniadou E, Vlachogianni G, Tsiantas C, Masullo M, Ioakeimidou A, Kondili E, Ntaganou M, Gkeka E, Papaioannou V, Polyzogopoulou E, Reininger AJ, De Pascale G, Kiehntopf M, Mouloudi E, Bauer M. Giamarellos-Bourboulis EJ, et al. Among authors: damoraki g. EBioMedicine. 2024 Nov;109:105414. doi: 10.1016/j.ebiom.2024.105414. Epub 2024 Oct 23. EBioMedicine. 2024. PMID: 39447386 Free PMC article.
qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial.
Adami ME, Kotsaki A, Antonakos N, Giannitsioti E, Chalvatzis S, Saridaki M, Avgoustou C, Akinosoglou K, Dakou K, Damoraki G, Katrini K, Koufargyris P, Lekakis V, Panagaki A, Safarika A, Eugen-Olsen J, Giamarellos-Bourboulis EJ. Adami ME, et al. Among authors: damoraki g. Crit Care. 2024 Feb 6;28(1):42. doi: 10.1186/s13054-024-04825-2. Crit Care. 2024. PMID: 38321472 Free PMC article. Clinical Trial.
Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients.
Engel JJ, van der Made CI, Keur N, Setiabudiawan T, Röring RJ, Damoraki G, Dijkstra H, Lemmers H, Ioannou S, Poulakou G, van der Meer JWM, Giamarellos-Bourboulis EJ, Kumar V, van de Veerdonk FL, Netea MG, Ziogas A. Engel JJ, et al. Among authors: damoraki g. Front Immunol. 2023 Aug 8;14:1233318. doi: 10.3389/fimmu.2023.1233318. eCollection 2023. Front Immunol. 2023. PMID: 37614228 Free PMC article.
Procalcitonin-guided early cessation of antibiotics prevents gut inflammation and preserves gut microbiome: Data from the PROGRESS controlled trial.
Kyriazopoulou E, Stylianakis E, Damoraki G, Koufargyris P, Kollias I, Katrini K, Drakou E, Marousis K, Spyrou A, Symbardi S, Alexiou N, Alexiou Z, Lada M, Poulakou G, Chrysos G, Adamis G, Giamarellos-Bourboulis EJ. Kyriazopoulou E, et al. Among authors: damoraki g. Int J Antimicrob Agents. 2025 Aug;66(2):107507. doi: 10.1016/j.ijantimicag.2025.107507. Epub 2025 Apr 9. Int J Antimicrob Agents. 2025. PMID: 40216091 Clinical Trial.
ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients.
Karakike E, Dalekos GN, Koutsodimitropoulos I, Saridaki M, Pourzitaki C, Papathanakos G, Kotsaki A, Chalvatzis S, Dimakopoulou V, Vechlidis N, Paramythiotou E, Avgoustou C, Ioakeimidou A, Kouriannidi E, Komnos A, Neou E, Rovina N, Stefanatou E, Milionis H, Nikolaidis G, Koutsoukou A, Damoraki G, Dimopoulos G, Zoumpos V, Eugen-Olsen J, Akinosoglou K, Gatselis NK, Koulouras V, Gkeka E, Markou N, Netea MG, Giamarellos-Bourboulis EJ. Karakike E, et al. Among authors: damoraki g. J Innate Immun. 2022;14(3):218-228. doi: 10.1159/000519090. Epub 2021 Dec 1. J Innate Immun. 2022. PMID: 34852352 Free PMC article.
Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects.
Tziatzios G, Stylianakis E, Damoraki G, Gkolfakis P, Leite G, Mathur R, Pimentel M, Giamarellos-Bourboulis EJ, Triantafyllou K. Tziatzios G, et al. Among authors: damoraki g. Neurogastroenterol Motil. 2025 Jan;37(1):e14955. doi: 10.1111/nmo.14955. Epub 2024 Nov 3. Neurogastroenterol Motil. 2025. PMID: 39491051 Free PMC article.
38 results